Why Cardiff Oncology Stock Skyrocketed Today

Keith Speights, The Motley Fool
·2-min read
Why Cardiff Oncology Stock Skyrocketed Today
Why Cardiff Oncology Stock Skyrocketed Today

Shares of Cardiff Oncology (NASDAQ: CRDF) were skyrocketing 21.1% higher as of 3:07 p.m. EDT on Thursday. The big jump came after Piper Sandler analyst Joseph Catanzaro initiated coverage on the stock with an overweight rating. Catanzaro also set a price target for Cardiff of $25, which reflects an 85% premium over the stock's closing price on Wednesday.